Benjamin F. Edwards & Company’s St Jude Medical STJ Stock Holding History

Benjamin F. Edwards & Company’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-242	Closed	-$19K	–	1428
2016 Q4	$19K	Hold	242	–	–	﹤0.01%	816
2016 Q3	$19K	Buy	242 +1	+0.4%	+$81	﹤0.01%	724
2016 Q2	$19K	Sell	241 -41	-15%	-$2.92K	﹤0.01%	684
2016 Q1	$16K	Sell	282 -391	-58%	-$21.3K	﹤0.01%	720
2015 Q4	$42K	Sell	673 -247	-27%	-$15.6K	0.01%	554
2015 Q3	$58K	Buy	920 +124	+16%	+$8.85K	0.01%	492
2015 Q2	$58K	Buy	796 +2	+0.3%	+$144	0.01%	565
2015 Q1	$52K	Buy	+794	New	+$52.8K	0.01%	564

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Benjamin F. Edwards & Company's STJ Position: Q1 2017 in Review

Benjamin F. Edwards & Company sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 242 shares — an estimated $19K sold.

Benjamin F. Edwards & Company first reported a position in STJ in Q1 2015 and held it in 8 quarters. The position peaked at $58K in Q3 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Benjamin F. Edwards & Company reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Benjamin F. Edwards & Company sold 242 St Jude Medical shares in Q1 2017, an estimated $19K.
Benjamin F. Edwards & Company first reported a position in St Jude Medical in Q1 2015 and held it in 8 quarters.
Benjamin F. Edwards & Company's St Jude Medical position peaked at $58K in Q3 2015.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2017, filed 4 May 2017.